Drug developer City Therapeutics files for US IPO

By Reuters News

- Drug developer City Therapeutics filed for an initial public offering in the US on Thursday.

The Cambridge, Massachusetts-based company plans to sell new shares in the IPO.

City Therapeutics will list on the Nasdaq under the symbol “CTY.”

Goldman Sachs, Jefferies, ​Stifel and ​Oppenheimer are the underwriters for the offering.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk